ClinicalTrials.gg

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Lumos Pharma, Inc. clinical trials

Also known as NewLink Genetics.

Part of Double Point Ventures LLC, which holds 100% as of 2024-12-12. Source

The registry lists 42 studies whose lead sponsor is Lumos Pharma, Inc.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.

Keep track of what changes. Save the Lumos Pharma, Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
21
Terminated
14
Not yet recruiting
3
Enrolling by invitation
1
Withdrawn
1
Recruiting
1

Phase

Phase 2
27
Phase 1
20
Phase 3
5
Early Phase 1
1

Where

United States
37
Australia
3
Poland
3
Ukraine
2
New Zealand
2
Chile
2

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Lumos Pharma, Inc..

  • NewLink Genetics Corporation
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    34 studies
  • Lumos Pharma
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies

Studies

Recruiting first, then most recently updated. Showing 42 of 42.